MASH-TAG 2027 Abstracts

Poster Presentations: All accepted abstracts will be presented as posters.

• Posters must be A0 size (approx. 33″ width × 47″ height), portrait format.
• Posters should have the MASH-TAG 2027 logo added to them (provided upon selection notification).
• Oral Presentations: Five (5) top-scoring abstracts will be selected for oral presentation based on scientific merit, novelty, and clinical relevance.

• Clinical Epidemiology – Steatotic Liver Disease, Obesity, Cholestasis, Viral, and Metabolic Liver Disease
• Diagnostic Procedures – Steatotic Liver Disease and Liver Fibrosis
• Therapeutic Trials – Steatotic Liver Disease, Cholestatic Liver Disease, Viral Hepatitis, Obesity, and Liver Fibrosis (Humans)
• Clinical Trial Design
• Disease Management of Steatotic/Viral/Cholestatic Liver Disease and Metabolic Comorbidities
• Obesity and Metabolic Dysfunction in Liver Disease
• Pharmacoeconomic and Societal Aspects
• Real-World Evidence and Outcomes Research
• Experimental/Basic Science – Liver Disease and Obesity (Non-human)
• Pathogenesis and Translational Science – Liver Disease and Liver Fibrosis (Humans)
• Pharmacology and Emerging Therapeutics
• Non-Invasive Testing and Biomarkers
• Imaging and Digital Health in Liver Disease
• Pediatric Steatotic Liver Disease and Obesity

• Clinical trials (all phases)
• Observational and real-world studies
• Translational research
• Diagnostic and biomarker studies
• Health outcomes and pharmacoeconomic research
• Basic and preclinical science

Industry-sponsored and investigator-initiated studies are permitted.

Studies involving investigational therapies are allowed.

• Encore abstracts must be clearly identified at submission.
• Eligible for poster presentation.
• Not eligible for awards or oral presentation unless they include substantial new data, at Course Director discretion.

Late-breaking abstracts should present:

• Recently completed clinical trials
• Practice-changing data
• Major safety or efficacy findings
• High-impact translational results

• Maximum 500 words (excluding title and authors).
• Tables and Figures: a maximum of 3 tables and/or figures (including charts and graphs) may be included with the abstract submission. Tables and figures should be clear, legible, and directly relevant to the data presented in the abstract.

• $150.00 per abstract submission
• $200.00 for Late-Breaking submission

• At least one author must register for the meeting.
• Poster presenters must be present during assigned poster sessions.
• Oral presenters must adhere to assigned presentation times.